Rxiv cytoskeleton📰 "CU104, a novel barrier function enhancer, improves colitis via modulation of barrier function and immune cell recruitment"
https://doi.org/doi:10.3389/fimmu.2026.1767762
https://pubmed.ncbi.nlm.nih.gov/41884837/
#Actin
https://doi.org/doi:10.3389/fimmu.2026.1767762
https://pubmed.ncbi.nlm.nih.gov/41884837/
#Actin
Frontiers | CU104, a novel barrier function enhancer, improves colitis via modulation of barrier function and immune cell recruitment
BackgroundInflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, is a chronic and relapsing condition with complex pathogenesis ...